CoChat

Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

Open access
Su, Yi, Flores, Shaney, Wang, Guoqiao, Hornbeck, Russ C., Speidel, Benjamin, Joseph‐Mathurin, Nelly, Vlassenko, Andrei G., Gordon, Brian A., Koeppe, Robert A., Klunk, William E., Jack, Clifford R., Farlow, Martin R., Salloway, Stephen, Snider, Barbara J., Berman, Sarah B., Roberson, Erik D., Brosch, Jared, Jimenez‐Velazques, Ivonne, van Dyck, Christopher H., Galasko, Douglas, Yuan, Shauna H., Jayadev, Suman, Honig, Lawrence S., Gauthier, Serge, Hsiung, Ging‐Yuek R., Masellis, Mario, Brooks, William S., Fulham, Michael, Clarnette, Roger, Masters, Colin L., Wallon, David, Hannequin, Didier, Dubois, Bruno, Pariente, Jeremie, Sanchez‐Valle, Raquel, Mummery, Catherine, Ringman, John M., Bottlaender, Michel, Klein, Gregory, Milosavljevic‐Ristic, Smiljana, McDade, Eric, Xiong, Chengjie, Morris, John C., Bateman, Randall J., Benzinger, Tammie L.S. · 2019 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Cited by 135

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Introduction: Quantitative in vivo measurement of brain amyloid burden is important for both research and clinical purposes. However, the existence of multiple imaging tracers presents challenges to the interpretation of such measurements. This study presents a direct comparison of Pittsburgh compound B–based and florbetapir‐based amyloid imaging in the same participants from two independent cohorts using a crossover design. Methods: Pittsburgh compound B and florbetapir amyloid PET imaging data from three different cohorts were analyzed using previously established pipelines to obtain global amyloid burden measurements. These measurements were converted to the Centiloid scale to allow fair comparison between the two tracers. The mean and inter‐individual variability of the two tracers were compared using multivariate linear models both cross‐sectionally and longitudinally. Results: Global amyloid burden measured using the two tracers were strongly correlated in both cohorts. However, higher variability was observed when florbetapir was used as the imaging tracer. The variability may be partially caused by white matter signal as partial volume correction reduces the variability and improves the correlations between the two tracers. Amyloid burden measured using both tracers was found to be in association with clinical and psychometric measurements. Longitudinal comparison of the two tracers was also performed in similar but separate cohorts whose baseline amyloid load was considered elevated (i.e., amyloid positive). No significant difference was detected in the average annualized rate of change measurements made with these two tracers. Discussion: Although the amyloid burden measurements were quite similar using these two tracers as expected, difference was observable even after conversion into the Centiloid scale. Further investigation is warranted to identify optimal strategies to harmonize amyloid imaging data acquired using different tracers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dadm.2018.12.008

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 135

Metadata

Authors
Su, Y., Flores, S., Wang, G., Hornbeck, R. C., Speidel, B., Joseph‐Mathurin, N., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., Jack, C. R., Farlow, M. R., Salloway, S., Snider, B. J., Berman, S. B., Roberson, E. D., Brosch, J., Jimenez‐Velazques, I., van Dyck, C. H., Galasko, D., Yuan, S. H., Jayadev, S., Honig, L. S., Gauthier, S., Hsiung, G. R., Masellis, M., Brooks, W. S., Fulham, M., Clarnette, R., Masters, C. L., Wallon, D., Hannequin, D., Dubois, B., Pariente, J., Sanchez‐Valle, R., Mummery, C., Ringman, J. M., Bottlaender, M., Klein, G., Milosavljevic‐Ristic, S., McDade, E., Xiong, C., Morris, J. C., Bateman, R. J., & Benzinger, T. L. S.
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2019-02-22
Volume
11
Issue
1
Pages
180-190
ISSN
2352-8729 (ISSN-L)
OpenAlex
W2948007219
Cited by
135
References
19
FWCI
12.12
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies. https://app.cochat.ai/papers/10.1016/j.dadm.2018.12.008
The paper
Su, Y., Flores, S., Wang, G., Hornbeck, R. C., Speidel, B., Joseph‐Mathurin, N., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., Jack, C. R., Farlow, M. R., Salloway, S., Snider, B. J., Berman, S. B., Roberson, E. D., Brosch, J., Jimenez‐Velazques, I., van Dyck, C. H., . . . Benzinger, T. L. S. (2019). Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2018.12.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.